C8..
CANCELLED SEC. 8 (6-YR)
08/07/2026
Back to search
Official data from USPTO
ARINGAGE
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
CANCELLED SEC. 8 (6-YR)Type: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
CANCELLED SEC. 8 (6-YR)
Case type
Application and registration
Recorded events
32
Latest update
08/07/2026
Trademark type
Word
Nice classes
5
Filing date
04/30/2018
Registration date
01/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2026
Last transaction
08/07/2026
Responsible office
United States Patent and Trademark Office
Status code
710
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Gangnam-gu, Seoul, KR
Examiner
FATHY, DOMINIC
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CMG Pharmaceutical Co.,Ltd.
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment of cardiovascular diseasecentral nervous system disease and disordersneurological disordersurologicalurogenital and urinary disordersgastrointestinal disordersmusculoskeletal disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseaseauto-immune disease; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular diseasecentral nervous system disease and disordersneurological disordersurologicalurogenital and urinary disordersgastrointestinal disordersmusculoskeletal disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseaseauto-immune disease; biological preparations for medical purposes for the treatment of cardiovascular diseasecentral nervous system disease and disordersneurological disordersurologicalurogenital and urinary disordersgastrointestinal disordersmusculoskeletal disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseaseauto-immune disease; drugs for medical purposes for the treatment of cardiovascular diseasecentral nervous system disease and disordersneurological disordersurologicalurogenital and urinary disordersgastrointestinal disordersmusculoskeletal disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseaseauto-immune disease; pharmaceuticals for the treatment of cardiovascular diseasecentral nervous system disease and disordersneurological disordersurologicalurogenital and urinary disordersgastrointestinal disordersmusculoskeletal disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseaseauto-immune disease; multivitamins preparations; pharmaceutical preparations for diagnosis for medical orveterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular diseasecentral nervous system disease and disordersneurological disordersurologicalurogenital and urinary disordersgastrointestinal disordersmusculoskeletal disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseaseauto-immune disease; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular diseasecentral nervous system disease and disordersneurological disordersurologicalurogenital and urinary disordersgastrointestinal disordersmusculoskeletal disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseaseauto-immune disease; antibiotics
Publications
History of USPTO decisions and trademark events.
32 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/28/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/14/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/14/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2019
PUBO
PUBLISHED FOR OPPOSITION
11/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/25/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/25/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
07/11/2019
GPRA
PRIORITY ACTION E-MAILED
07/11/2019
CPRA
PRIORITY ACTION WRITTEN
07/11/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/01/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/26/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
03/12/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/25/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2019
ALIE
ASSIGNED TO LIE
02/13/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2018
GNRT
NON-FINAL ACTION E-MAILED
08/21/2018
CNRT
NON-FINAL ACTION WRITTEN
08/21/2018
DOCK
ASSIGNED TO EXAMINER
08/21/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2018
NWAP
NEW APPLICATION ENTERED
05/03/2018
Continuous trademark protection
Get notified about every new filing that threatens ARINGAGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.